Skip to main content

Table 3 Summary of the base case analysis

From: Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine

  Intervention Estimated
5-year costs
QALY gained Difference (cost) Difference (QALY) Cost per QALY
deterministic Mezavant 4,940 € 3.320 -624 € 0.011 NA
  Asacol 5,564 € 3.309    
probabilistic Mezavant 4,939 € 3.320 -705 € 0.022 NA
  Asacol 5,644 € 3.330